Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacarbazine in Metastatic Soft Tissue and Bone Sarcoma
NCT00802880Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2009
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dacarbazine in soft tissue sarcoma (STS), bone sarcoma, sponsored by Washington University School of Medicine. Started Mar 2009; status: completed.
02
Drugs
dacarbazine
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT00802880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802880.